Literature DB >> 9868619

Assessment of person-to-person transmission of hantavirus pulmonary syndrome in a Chilean hospital setting.

J Chaparro1, J Vega, W Terry, J L Vera, B Barra, R Meyer, C J Peters, A S Khan, T G Ksiazek.   

Abstract

Person-to-person transmission of Andes hantavirus among healthcare workers was reported in Argentina for the first time in 1996. To determine whether such transmission of the virus occurred during a 1997 outbreak of hantavirus pulmonary syndrome (HPS) in southern Chile due to Andes virus, we conducted a serological and epidemiological study in the Coyhaique Regional Hospital, where the majority of HPS patients were admitted. Workers in every department of the hospital were evaluated for immunoglobulin G (IgG) and IgM hantavirus antibodies using the enzyme-linked immunosorbent assay (ELISA). A standardized questionnaire was used to determine the type and extent of exposure to HPS patients, as well as other potential risk factors and previous febrile respiratory illnesses requiring hospitalization. Less than half (44%) reported always using gloves when touching patients or their secretions; respiratory protection was not used. Of the 319 participants (87.9% of those eligible), 12 (3.7%) had IgG antibodies. This finding is consistent with the antibody prevalence in the community in which the participants lived. Of the 12 positive healthcare workers, six reported contact with HPS patients. A similar exposure was found in those who tested negative [6/140 (4%) compared to 6/179 (3%), P = 0.66]. There was no significant difference in the types of hospital activities performed or the number of hospitalizations for febrile respiratory illnesses between antibody-positive and antibody-negative individuals. These data suggest that there was no person-to-person transmission among healthcare workers during a recent outbreak of HPS in Southern Chile in 1997, despite the inconsistent use of any precautions against transmission.

Entities:  

Mesh:

Year:  1998        PMID: 9868619     DOI: 10.1016/s0195-6701(98)90304-8

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  14 in total

Review 1.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

Review 2.  Human pathogenic hantaviruses and prevention of infection.

Authors:  Detlev H Krüger; Günther Schönrich; Boris Klempa
Journal:  Hum Vaccin       Date:  2011-06-01

3.  Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review.

Authors:  Joao Toledo; Michelle M Haby; Ludovic Reveiz; Leopoldo Sosa Leon; Rodrigo Angerami; Sylvain Aldighieri
Journal:  J Infect Dis       Date:  2022-10-17       Impact factor: 7.759

4.  Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus.

Authors:  Dong-Hoon Chung; Sidath C Kumarapperuma; Yanjie Sun; Qianjun Li; Yong-Kyu Chu; Jeffrey B Arterburn; William B Parker; Jeffrey Smith; Kristin Spik; Harish N Ramanathan; Connie S Schmaljohn; Colleen B Jonsson
Journal:  Antiviral Res       Date:  2008-03-17       Impact factor: 5.970

5.  Hantavirus pulmonary syndrome, United States, 1993-2009.

Authors:  Adam MacNeil; Thomas G Ksiazek; Pierre E Rollin
Journal:  Emerg Infect Dis       Date:  2011-07       Impact factor: 6.883

6.  Small interfering RNA inhibition of Andes virus replication.

Authors:  Cheng-Feng Chiang; Cesar G Albariňo; Michael K Lo; Christina F Spiropoulou
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

7.  Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011.

Authors:  Constanza Martinez-Valdebenito; Mario Calvo; Cecilia Vial; Rita Mansilla; Claudia Marco; R Eduardo Palma; Pablo A Vial; Francisca Valdivieso; Gregory Mertz; Marcela Ferrés
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

8.  A Novel Hantavirus of the European Mole, Bruges Virus, Is Involved in Frequent Nova Virus Coinfections.

Authors:  Lies Laenen; Valentijn Vergote; Liana Eleni Kafetzopoulou; Tony Bokalanga Wawina; Despoina Vassou; Joseph A Cook; Jean-Pierre Hugot; Ward Deboutte; Hae Ji Kang; Peter T Witkowski; Panja Köppen-Rung; Detlev H Krüger; Martina Licková; Alexander Stang; Lucia Striešková; Tomáš Szemeš; Janusz Markowski; Janusz Hejduk; Dimitris Kafetzopoulos; Marc Van Ranst; Richard Yanagihara; Boris Klempa; Piet Maes
Journal:  Genome Biol Evol       Date:  2018-01-01       Impact factor: 3.416

9.  Platelet Count in Patients with Mild Disease at Admission is Associated with Progression to Severe Hantavirus Cardiopulmonary Syndrome.

Authors:  René López; Cecilia Vial; Jerónimo Graf; Mario Calvo; Marcela Ferrés; Gregory Mertz; Analía Cuiza; Begonia Agüero; Dante Aguilera; Diego Araya; Ignacia Pailamilla; Flavia Paratori; Víctor Torres-Torres; Pablo A Vial
Journal:  Viruses       Date:  2019-07-30       Impact factor: 5.048

Review 10.  Hantavirus Cardiopulmonary Syndrome Due to Imported Andes Hantavirus Infection in Switzerland: A Multidisciplinary Challenge, Two Cases and a Literature Review.

Authors:  Andrea B Kuenzli; Jonas Marschall; Joerg C Schefold; Margaret Schafer; Oliver B Engler; Rahel Ackermann-Gäumann; David C Reineke; Franziska Suter-Riniker; Cornelia Staehelin
Journal:  Clin Infect Dis       Date:  2018-11-13       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.